Chronic Recurrent Multifocal Osteomyelitis
6
3
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
16.7%
1 terminated out of 6 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Reliability and Validation of the WB-MRI Radiological Score in CRMO
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
CHronic Nonbacterial Osteomyelitis International Registry
Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)
Chronic Recurrent Multifocal Osteomyelitis - a Bacterial Cause?
Post-transition Clinical and Socio-professional Future in Adult Patients With Recurrent Multifocal Chronic Osteitis